| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.76B | +14.9% |
| Cost of Revenue | $7.14B | +13.8% |
| Gross Profit | $2.62B | +18.0% |
| R&D Expense | $106.0M | +16.5% |
| Operating Income | $1.71B | +19.2% |
| Interest Expense | $109.0M | -13.5% |
| Pre-tax Income | $1.61B | +22.9% |
| Income Tax | $373.0M | +16.9% |
| Net Income | $1.24B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.10B | +14.6% |
| Accounts Receivable | $961.0M | +2.3% |
| Inventory | $1.33B | +23.7% |
| Current Assets | $3.56B | +14.8% |
| Total Assets | $10.75B | +7.4% |
| Current Liabilities | $2.10B | +24.0% |
| Long-term Debt | $3.02B | +1.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.76B | +17.1% |
| Investing Cash Flow | -$623.0M | -65.3% |
| Financing Cash Flow | -$974.0M | -10.6% |
| +24.7% |
| EPS (Basic) | $12.85 | +33.7% |
| EPS (Diluted) | $12.70 | +33.1% |
| Total Liabilities |
| $6.13B |
| +7.9% |
| Stockholders' Equity | $4.58B | +6.5% |